Aceon
(Perindopril)Phase 3Small molecule
Institut de Recherches Internationales ServierPerindopril is used to treat high blood pressure and to help the heart work more efficiently after a heart attack or in heart failure. It works by relaxing blood vessels to allow blood to flow more easily.[1] Aceon is currently being investigated across 3 indications[3], with its most advanced program in Phase 3.[1]
Aceon is one of 107 small molecule programs targeting Cardiovascular Disease. It is currently in Phase 3.
3
Indications
27
Total Trials
1
Active Trials
106
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
206 competitors in Heart Failure
#DrugCompanyPhaseTrials
1Aceon
Institut de Recherches Internationales ServierPhase 3
Bayer Aspirin
BayerPreclinical
Brethine
SanofiPreclinical
Medrol
PfizerPreclinical
Amidate
PfizerPreclinical
Activase
RochePreclinical
Zemplar
AbbViePreclinical
Adriamycin
PfizerPreclinical
Savaysa
Daiichi SankyoPreclinical
Xifaxan
SSalix
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Hypertension5 trials
Blood Pressure2 trials
Angiotensin Converting Enzyme2 trials
Alcoholic Fatty Liver Disease1 trial
16 more indications
Body Weight1 trial
Dilated Cardiomyopathy1 trial
PREclinical Mutation CARriers From Families With DIlated Cardiomyopathy and ACE Inhibitors
Terminated·IInstitut National de la Santé Et de la Recherche Médicale, France·Phase 3·NCT01583114·6 enrolled
Hematoma1 trial
Chronic Kidney Disease1 trial
Effect of Valsartan vs Perindopril on HOMA-IR Index in Patients With Chronic Kidney Disease
Unknown status·—·Phase 4·NCT02299310·60 enrolled
Methamphetamine Dependence1 trial
An ACE Inhibitor (Perindopril) or an Angiotensin Receptor Blocker (Candesartan) as a Treatment for Methamphetamine Dependence
Completed·—·Phase 1·NCT01062451·80 enrolled
PTSD1 trial
DOXAZOSIN FOR PTSD
Completed·—·Phase 1·NCT02308202·30 enrolled
Marfan syndrome1 trial
Comparison of Medical Therapies in Marfan Syndrome.
Completed·—·Phase 4·NCT01295047·18 enrolled
Type 2 Diabetes1 trial
Fasting Conditions1 trial
Cerebral Small Vessel Disease1 trial
Unspecified1 trial
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Perindopril. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details